Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 21 June, 2024
    In this study, Thayabaran Kathiresan, Redenlab’s Director of Audio Engineering, co-authors "Cortical-striatal brain network distinguishes deepfake from real speaker identity”....
    • Posted on 17 June, 2024
      Up to half of all people with multiple sclerosis experience communication difficulties due to dysarthria, a disorder that impacts the...
      • Posted on 7 June, 2024
        Redenlab’s CEO, Adam Vogel, co-wrote "The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia"...